Frontier in Medical & Health Research
EXPLAINABLE MULTI-OMICS AI FOR PRECISION RISK STRATIFICATION OF INHERITED DISORDERS IN PAKISTANI FAMILIES
PDF

Keywords

Explainable Artificial Intelligence; Multi-Omics; Inherited Disorders; Precision Medicine; Risk Stratification; Pakistani Families.

How to Cite

EXPLAINABLE MULTI-OMICS AI FOR PRECISION RISK STRATIFICATION OF INHERITED DISORDERS IN PAKISTANI FAMILIES. (2026). Frontier in Medical and Health Research, 4(3), 4279-4294. https://fmhr.net/index.php/fmhr/article/view/3793

Abstract

Inherited disorders present substantial challenges for accurate diagnosis and individualized risk assessment, particularly in genetically diverse and highly consanguineous populations. This study examined an explainable multi-omics artificial intelligence (AI) framework for precision risk stratification of inherited disorders among Pakistani families. A quantitative predictive design was employed using integrated genomic, transcriptomic, proteomic, metabolomic, familial, and clinical indicators. Multiple machine-learning algorithms were compared using accuracy, precision, recall, F1-score, and area under the receiver operating characteristic curve (AUC), while SHAP-based explainable AI was applied to identify the principal contributors to individual risk predictions. The analysis indicated that Gradient Boosting achieved the strongest predictive performance (accuracy = 87.6%; AUC = .94), compared with genomic information alone (accuracy = 78.9%; AUC = .83). Integration of clinical and multi-omics information increased the AUC from .83 to .94. Pathogenic genomic variants, multi-omics risk scores, clinical phenotype severity, family history, and consanguinity emerged as major predictive features. The findings suggest that integrating heterogeneous molecular and clinical information with explainable AI can provide a more comprehensive and interpretable approach to inherited-disorder risk stratification. The framework may support precision diagnosis, genetic counselling, family screening, and individualized clinical decision-making in Pakistan. However, the reported numerical results require validation using real-world, longitudinal, and independently collected Pakistani datasets.

PDF